Evidence‐based review of the nutritional treatment of obesity and metabolic dysfunction‐associated steatotic liver disease in children and adolescents
Journal of Pediatric Gastroenterology and Nutrition · 2025-09 · 81 (3) · 485-496
DOI: 10.1002/jpn3.70099 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 17.06.2025. Verfasst von Sara Karjoo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Gastroenterology, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA. Hauptthemen laut MEDLINE: Pediatric Obesity, Fatty Liver, Nutrition Therapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 90 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
The growing pediatric obesity epidemic has paralleled the surge in metabolic dysfunction‐associated steatotic liver disease (MASLD) and metabolic dysfunction‐associated steatohepatitis. It develops due to nutritional imbalances, microbiome dysbiosis, gene regulation, hormonal changes, and environmental factors like food deserts, low activity level, and an unhealthy lifestyle. The prevalence of MASLD and obesity is rising every year. Lifestyle changes remain the mainstay treatment for obesity and MASLD. Per the 2023 American Association for the Study of Liver Diseases Practice Guidance on MASLD, achieving ≥5% weight loss can reduce hepatic steatosis, ≥7% weight loss can reduce hepatic inflammation, and ≥10% weight loss can reduce liver fibrosis. Therefore, nutritional interventions can be a powerful tool to help correct metabolic dysfunction and promote healthy weight loss. Current endorsed nutritional interventions for weight loss or MASLD include the Mediterranean diet, low glycemic/low carbohydrate diet, plant‐based diet/anti‐inflammatory diet, ketogenic diet, and intermittent fasting. This review provides evidence‐based insights into current nutritional interventions for children and adolescents with obesity and MASLD to help guide pediatric gastroenterologists in making the best dietary‐based recommendations in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Pediatric Gastroenterology, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
- University of South Florida, Tampa, Florida, USA.
- Florida State University, Tallahassee, Florida, USA.
- Amerita Home Infusion, Greenwood Village, Colorado, USA.
- David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
- Unidad Médica de Alta Especialidad, Instituto Mexicano del Seguro Social, Mérida, Yucatán, México.
ORCID-Profile: Sara Karjoo
Zitieren
APA
Karjoo, S., Braglia-Tarpey, A., Chan, A. P., Ayala Germán, A. G., Herdes, R. E., Pai, N., Sierra-Velez, D., Whitehead, B., Quiros-Tejeira, R. E., & Duro, D. (2025). Evidence‐based review of the nutritional treatment of obesity and metabolic dysfunction‐associated steatotic liver disease in children and adolescents. Journal of Pediatric Gastroenterology and Nutrition, 81(3), 485-496. https://doi.org/10.1002/jpn3.70099
Vancouver
Karjoo S, Braglia-Tarpey A, Chan AP, Ayala Germán AG, Herdes RE, Pai N, et al. Evidence‐based review of the nutritional treatment of obesity and metabolic dysfunction‐associated steatotic liver disease in children and adolescents. Journal of Pediatric Gastroenterology and Nutrition. 2025;81(3):485-496. doi:10.1002/jpn3.70099
BibTeX
@article{Karjoo2025,
author = {Karjoo, Sara and Braglia-Tarpey, Amy and Chan, Alvin P and Ayala Germán, Ana Gabriela and Herdes, Rachel E and Pai, Nikhil and Sierra-Velez, Desiree and Whitehead, Bridget and Quiros-Tejeira, Ruben E and Duro, Debora},
title = {Evidence‐based review of the nutritional treatment of obesity and metabolic dysfunction‐associated steatotic liver disease in children and adolescents},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2025},
volume = {81},
number = {3},
pages = {485--496},
doi = {10.1002/jpn3.70099}
}
EUVIMED